Sigma Planning Corp Haleon PLC Transaction History

Sigma Planning Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$8.02 - $8.67 $112,263 - $121,362	13,998 New	13,998 $118,000
Q3 2023 Nov 06, 2023	BUY	$7.85 - $8.94 $9,160 - $10,432	1,167 Added 8.09%	15,590 $129,000
Q2 2023 Aug 01, 2023	SELL	$8.04 - $9.0 $46,133 - $51,642	-5,738 Reduced 28.46%	14,423 $120,000
Q1 2023 May 05, 2023	SELL	$7.57 - $8.37 $40,779 - $45,089	-5,387 Reduced 21.09%	20,161 $164,000
Q4 2022 Jan 24, 2023	SELL	$5.96 - $8.06 $42,691 - $57,733	-7,163 Reduced 21.9%	25,548 $0
Q3 2022 Nov 10, 2022	BUY	$5.63 - $7.5 $184,162 - $245,332	32,711 New	32,711 $199,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.